SCHEMBL1504756

SCHEMBL1504756

CCC(Cl)(Cl)[C](Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL959546 0.73
SCHEMBL9328781 0.73
SCHEMBL10533446 0.73
SCHEMBL16969922 0.71
SCHEMBL11173848 0.69
SCHEMBL6414112 0.69 FDPS (0.39)
SCHEMBL16969836 0.69
SCHEMBL11388928 0.67
SCHEMBL10470535 0.67
SCHEMBL1708069 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5262420-A Phenylalkylpyridines IDEMITSU KOSAN CO., LTD. (JP) 1993-11-16 US claimed
US-4289712-A Tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1981-09-15 US claimed
US-4247489-A Process for preparing tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1981-01-27 US claimed
US-4207272-A Tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1980-06-10 US claimed
US-8173684-B2 Pyridone derivatives as p38α MAPK inhibitors ASTELLAS PHARMA INC. (JP) 2012-05-08 US disclosed
EP-2155683-B8 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC (JP) 2011-09-21 EP disclosed
EP-2155683-B1 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC (JP) 2011-03-16 EP disclosed
US-20100063098-A1 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC. (JP) 2010-03-11 US disclosed
EP-2155683-A2 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS Astellas Pharma Inc. (JP) 2010-02-24 EP disclosed
WO-2008140066-A2 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC. (JP) 2008-11-20 WO disclosed
US-20080033033-A1 8-AZAPROSTAGLANDIN DERIVATIVES AND MEDICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. 2008-02-07 US disclosed
US-7256211-B1 8-azaprostaglandin derivatives and medical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-08-14 US disclosed
US-4289712-A Tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1981-09-15 US disclosed
US-4289712-A Tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1981-09-15 US disclosed
US-4247489-A Process for preparing tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1981-01-27 US disclosed
US-4247489-A Process for preparing tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1981-01-27 US disclosed
US-4247489-A Process for preparing tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1981-01-27 US disclosed
US-4207272-A Tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1980-06-10 US disclosed
US-4207272-A Tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1980-06-10 US disclosed
US-4207272-A Tetrachloro-butyl secondary phosphites OLIN CORPORATION (US) 1980-06-10 US disclosed